-

Lost Money on Dave, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 21.25% Stock Decline

Investigation centers on the November 4, 2026 news about Dave, Inc.; investors with losses may have potential claims to recover them

LOS ANGELES--(BUSINESS WIRE)--Dave, Inc. ("Dave" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Dave, Inc. (NASDAQ: DAVE), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Dave, Inc. on November 4, 2026.

If you lost money on Dave, Inc. securities, share your Dave, Inc. loss information with the firm to learn about potentially pursuing a claim to recover your losses.

Dave, Inc. investigation at a glance

  • Date of disclosure: November 4, 2026
  • Share price decline: $71.45 per share, or 21.25%

What happened?

On November 4, 2026, Dave disclosed that it had received subpoenas and inquiries from government departments in Connecticut, Maryland, and New York. Among other things, the Company disclosed it received subpoenas from the New York State Department of Financial Services and the New York Attorney General requesting information regarding its products and services.

On this news, Dave stock fell as much as $71.45 or 21.25%, during intraday trading on November 5, 2026, thereby injuring investors.

"Dave, Inc. shares dropped 21.25% after it was disclosed on November 4, 2026 that Dave had received subpoenas and inquiries from government departments in Connecticut, Maryland and New York, including from the New York State Department of Financial Services and the New York Attorney General, regarding its products and services. Our investigation will look at whether investors had complete and accurate information before that disclosure," said Frank R. Cruz of The Law Offices of Frank R. Cruz.

What should Dave, Inc. investors do now?

The Law Offices of Frank R. Cruz is investigating potential claims on behalf of Dave, Inc. investors. Investors who lost money can visit the Dave, Inc. investigation page, email info@frankcruzlaw.com, or call 310-914-5007.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

Questions and answers about the Dave, Inc. investigation

Who is eligible? Investors who purchased Dave, Inc. securities and suffered losses may have claims, and can contact the firm to find out whether the Dave, Inc. investigation affects them.

What does a securities fraud investigation involve? In the Dave, Inc. investigation, The Law Offices of Frank R. Cruz is examining whether the Company or its executives may have made false or misleading statements to investors in violation of the federal securities laws.

Is there a lawsuit? This release announces an investigation by The Law Offices of Frank R. Cruz, not a lawsuit. If a securities class action is later filed against Dave, Inc., investors may be able to seek appointment as lead plaintiff.

How are attorneys' fees handled? The Law Offices of Frank R. Cruz works on contingency, so Dave, Inc. investors pay no attorneys' fees up front. Any attorneys' fees and litigation expenses come only from a recovery, if there is one, and require court approval.

Information for whistleblowers

Anyone with non-public information about Dave, Inc. should consider their options to assist the investigation or participate in the SEC Whistleblower Program. The program allows whistleblowers who provide original information leading to a successful SEC enforcement action to receive awards of 10 to 30 percent of the sanctions collected, when those sanctions exceed $1 million. For more information, contact Frank R. Cruz at 310-914-5007 or email info@frankcruzlaw.com.

About The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz investigates and prosecutes securities fraud and corporate malfeasance class actions. With nearly 20 years of litigation experience, the firm focuses on complex securities class actions and gives each client personal, one-on-one attention throughout the legal process.

Prior results do not guarantee a similar outcome.

Related links

Follow The Law Offices of Frank R. Cruz for updates on Twitter: twitter.com/FRC_LAW

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Frank R. Cruz
The Law Offices of Frank R. Cruz
Los Angeles, CA
Email: fcruz@frankcruzlaw.com
Telephone: 310-914-5007
www.frankcruzlaw.com

The Law Offices of Frank R. Cruz

NASDAQ:DAVE

Release Versions

Contacts

Frank R. Cruz
The Law Offices of Frank R. Cruz
Los Angeles, CA
Email: fcruz@frankcruzlaw.com
Telephone: 310-914-5007
www.frankcruzlaw.com

More News From The Law Offices of Frank R. Cruz

Lost Money on MNTN, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 53.62% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--MNTN, Inc. ("MNTN" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in MNTN, Inc. (NYSE: MNTN), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about MNTN, Inc. on November 4, 2026.If you lost money on MNTN, Inc. securities, share your...

Lost Money on Madrigal Pharmaceuticals, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 8.1% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Madrigal Pharmaceuticals, Inc. on Novem...

Deadline Alert: O-I Glass, Inc. Shareholders Have Until December 28, 2026 to Seek Lead Plaintiff Appointment in Securities Fraud Lawsuit, The Law Offices of Frank R. Cruz Notes

LOS ANGELES--(BUSINESS WIRE)--The deadline for O-I Glass, Inc. ("O-I Glass" or the "Company") (NYSE: OI) investors to seek appointment as lead plaintiff in a securities class action lawsuit is December 28, 2026. The lawsuit was filed on behalf of investors who purchased or otherwise acquired O-I Glass, Inc. securities from March 14, 2025 to July 28, 2026, inclusive. The Law Offices of Frank R. Cruz today reminded investors of the deadline in the case, Bryan v. O-I Glass, Inc. et al., filed on Oc...
Back to Newsroom